1989
DOI: 10.1016/0300-483x(89)90022-x
|View full text |Cite
|
Sign up to set email alerts
|

Hepatotoxicity of pulegone in rats: Its effects on microsomal enzymes, in vivo

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
17
0

Year Published

1992
1992
2017
2017

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 46 publications
(17 citation statements)
references
References 22 publications
0
17
0
Order By: Relevance
“…Unfortunately, widescale application of pulegone would be impossible because of its toxic properties. A number of large studies have shown that pulegone and its main metabolite, menthofuran, show hepato-and neurotoxicity as well as pulmonary toxicity toward vertebrates (Gordon et al 1982, Olsen and Thorup 1984, Moorthy et al 1989). …”
mentioning
confidence: 99%
“…Unfortunately, widescale application of pulegone would be impossible because of its toxic properties. A number of large studies have shown that pulegone and its main metabolite, menthofuran, show hepato-and neurotoxicity as well as pulmonary toxicity toward vertebrates (Gordon et al 1982, Olsen and Thorup 1984, Moorthy et al 1989). …”
mentioning
confidence: 99%
“…Hepatotoxic doses of pulegone, five daily doses of 400 mg/kg, decreased the amount of hepatic cytochromes P450 in rats based on total cytochrome P450 content and N-demethylase activity with a general substrate, aminopyrine. These parameters were also decreased following single doses of 200 but not 100 mg/kg (Moorthy et al, 1989). In the pretreatment study, distribution of a radiolabeled pulegone dose of 80 mg/kg following three daily 80 mg/kg doses of unlabeled pulegone showed some subtle differences from a single dose in naive animals.…”
Section: Disposition Of Pulegone In Mice and Ratsmentioning
confidence: 85%
“…It appears that changes in oxidase activity induced by relatively nontoxic doses of pulegone are minor, and those that have been observed may be more a result of hepatotoxicity. For example, Moorthy et al (1989) report an LD 50 of 245 mg/kg; they report decreases in enzymatic activity beginning at 200 mg/kg.…”
Section: Disposition Of Pulegone In Mice and Ratsmentioning
confidence: 99%
“…With regard to the former, the clinical cases of patients who ingested a large amount of pennyroyal oil resulted in hepatic toxicity that, upon further investigation, was classified as hepatic centrilobular necrosis. In mice and rats, intraperitoneal (ip) administration of pennyroyal oil resulted in dosedependent hepatotoxicity similar to that observed in human, and, thus, mouse and rat were determined to be appropriate hepatotoxicity models (Gordon et al, 1982;Mizutani et al, 1987;Moorthy et al, 1989a;Thomassen et al, 1988). The markers used for liver damage were plasma glutamic pyruvic transaminase (GPT) and glutathione (GSH).…”
Section: Determination Of Animal Models For and Toxins In Pennyroyal Oilmentioning
confidence: 93%